Latest News
QV Bioelectronics and Incubate Bio announce successful outcome of strategic collaboration to accelerate new treatment option for Glioblastoma
Collaboration delivered vital insights to advance revolutionary treatment modality – GRACE ALaSCA platform able to decipher experimental data from complex…
Read More
Michaela Joins QV as Summer Intern
Exciting News: Welcome Michaela Baek, Our New Summer Intern at QV Bioelectronics! ? Michaela, an aspiring biologist, is eager to…
Read More
QV Bioelectronics selected for TMC inaugural UK cohort
QV Bioelectronics are one of 16 leading digital health and medical device startups founded in the UK have been selected…
Read More
Press Release: QV Bioelectronics Awarded £860,000 Innovate UK Boost.
QV Bioelectronics Awarded £860,000 Innovate UK Boost. Funds awarded under Combined Investor Partnerships by Innovate UK, the UK’s innovation agency….
Read More
Kashmeera Koh joins the Team as Biomedical Engineer.
Hire #3 of 2023 joins the QV Bioelectronics team! ?? We are delighted to announce that Kashmeera Koh has joined QV as…
Read More
Tomisin Olukoga joins QV as Scientist, Cancer Biology
The team keeps on growing! ? We’re delighted to announce the arrival of Tomisin in the role of Scientist, Cancer Biology ??…
Read More@qvbio
@InnovateUK & @UKinTX hosted @michelledonelan on her visit to @TXMedCenter to meet the latest cohort of UK-based #DigitalHealth & #Medical device startups participating in the TMC Innovation accelerator, part of Innovate UK's Global Incubator Programme.
⚕️https://ow.ly/5vwI50Q8EP1
Now Presenting: Christopher Bullock of @qvbio (Cheshire, UK). They are developing the world’s first implantable electric field therapy device to treat aggressive brain cancers.
Are you staying informed?
http://bit.ly/3G0kLGa
🎉Presenting in the #Oncology Therapeutic Category at Innovation Summit San Francisco 2023 is Presenting Company QV Bioelectronics (@qvbio) with CEO Christopher Bullock.
🎉 Welcome to #InnovationSF23, Chris and the QV Bioelectronics team! We are delighted to have you.
@qvbio and @IncubateBio announce successful outcome of strategic collaboration to accelerate new treatment option for Glioblastoma
Our IDH mutant glioma heterogeneity paper with @hoheyn is out in @CellRepMed. A wonderful collective effort by @Enblacar, Ashwin, Inma, and @JuanCNieto1. Special thanks to Matthias and Luigi. Looking forward to expanding on this work!